Altered expression of cell cycle genes distinguishes aggressive neuroblastoma
- 13 December 2004
- journal article
- Published by Springer Nature in Oncogene
- Vol. 24 (9) , 1533-1541
- https://doi.org/10.1038/sj.onc.1208341
Abstract
In this study, gene expression profiling was performed on 103 neuroblastoma (NB) tumors, stages 1–4 with and without MYCN amplification, using cDNA microarrays containing 42 578 elements. Using principal component analysis (PCA) to analyse the relationships among these samples, we confirm that the global patterns of gene expression reflect the phenotype of the tumors. To explore the biological processes that may contribute to increasing aggressive phenotype of the tumors, we utilized a statistical approach based on PCA. We identified a specific subset of the cell cycle and/or chromosome segregation genes that distinguish stage 4 NB tumors from all lower stage tumors, including stage 3. Furthermore, the control of the kinetochore assembly emerges from the Gene Ontology analysis as one of the key biological processes associated with an aggressive NB phenotype. Finally, we establish that these genes are further upregulated in the most aggressive MYCN-amplified tumors.Keywords
This publication has 23 references indexed in Scilit:
- Prediction of Clinical Outcome Using Gene Expression Profiling and Artificial Neural Networks for Patients with NeuroblastomaCancer Research, 2004
- Gene expression profiling and identification of novel prognostic marker genes in neuroblastomaGenes, Chromosomes and Cancer, 2004
- Pediatric neuroblastomas: genetic and epigenetic ‘Danse Macabre’Gene, 2004
- Enhanced expression of MYCN leads to centrosome hyperamplification after DNA damage in neuroblastoma cellsOncogene, 2003
- Identification of Stk6/STK15 as a candidate low-penetrance tumor-susceptibility gene in mouse and humanNature Genetics, 2003
- Genomic targets of the human c-Myc proteinGenes & Development, 2003
- Does the ribosome translate cancer?Nature Reviews Cancer, 2003
- Neuroblastoma: biological insights into a clinical enigmaNature Reviews Cancer, 2003
- N-myc enhances the expression of a large set of genes functioning in ribosome biogenesis and protein synthesisThe EMBO Journal, 2001
- High expression of Survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastomaOncogene, 2000